Immunohistochemical analysis of suspicious lesions confirmed the presence of SSTR2-positive disease and demonstrated the high specificity of Ga67-MMC(IR800)-TOC for tumor-specific targeting while simultaneously showing the high detection sensitivity and spatial resolution of the device for detecting residual fluorescence in lesions that measured <2  mm in size (Fig. 7). The gene discussed is SSTR2; the disease is neoplasm.